116 related articles for article (PubMed ID: 7164768)
1. [Value of the probenecid test in the diagnosis and treatment of parkinson disease].
Vanderheyden JE; Noel G; Mendlewicz J
Acta Neurol Belg; 1982; 82(6):339-52. PubMed ID: 7164768
[TBL] [Abstract][Full Text] [Related]
2. Further observations showing the impact of the probenecid test in movement disorders.
Vanderheyden JE; Dumont JP; Dekoninck WJ; Mendlewicz J
Acta Neurol Belg; 1985; 85(3):171-81. PubMed ID: 4013657
[TBL] [Abstract][Full Text] [Related]
3. 14C-homovanillic acid in the cerebrospinal fluid of parkinsonian patients after intravenous 14C-L-dopa.
Extein I; Van Woert M; Roth RH; Bowers MB
Biol Psychiatry; 1976 Apr; 11(2):227-32. PubMed ID: 971447
[TBL] [Abstract][Full Text] [Related]
4. [Use of the probenecid test for the diagnosis and treatment of Parkinsonism. Review of the literature and personal experience (author's transl)].
Vanderheyden JE; Dekoninck WJ; Lefèvre A; Mendlewicz J
Encephale; 1980; 6(4):349-66. PubMed ID: 6160034
[TBL] [Abstract][Full Text] [Related]
5. [Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)].
Carrieri P; Campanella G; Mandarini A; Orefice G; Buscaino GA
Acta Neurol (Napoli); 1976; 31(5):558-64. PubMed ID: 1015382
[No Abstract] [Full Text] [Related]
6. Biochemical aids in the diagnosis of Parkinson's disease.
Chase TN; Eng N; Gordon EK
Ann Clin Lab Sci; 1976; 6(1):4-10. PubMed ID: 1247283
[TBL] [Abstract][Full Text] [Related]
7. CSF-changes of HVA and 5-HIAA during intermittent and continuous Parkinson therapy with particular regard to prodipin application.
Oppel F; Schulze G
Pharmakopsychiatr Neuropsychopharmakol; 1978 Mar; 11(2):76-80. PubMed ID: 347467
[TBL] [Abstract][Full Text] [Related]
8. CSF homovanillic acid: an index of dopaminergic activity.
Curzon G
Adv Neurol; 1975; 9():349-57. PubMed ID: 125031
[TBL] [Abstract][Full Text] [Related]
9. Clinical application of the probenecid test for measurement of monoamine turnover in the CNS.
Faull KF; Kraemer HC; Barchas JD; Berger PA
Biol Psychiatry; 1981 Sep; 16(9):879-99. PubMed ID: 6170352
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid probenecid studies: a reinterpretation.
Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
[TBL] [Abstract][Full Text] [Related]
11. Serotoninergic dysfunction in the 47, XYY syndrome.
Bioulac B; Benezech M; Renaud B; Noel B; Roche D
Biol Psychiatry; 1980 Dec; 15(6):917-23. PubMed ID: 6161648
[TBL] [Abstract][Full Text] [Related]
12. Juvenile parkinsonism: a patient with possible primary striatal dysfunction.
Naidu S; Wolfson LI; Sharpless NS
Ann Neurol; 1978 May; 3(5):453-5. PubMed ID: 727726
[TBL] [Abstract][Full Text] [Related]
13. Homovanillic acid in the cerebrospinal fluid of Parkinsonian patients.
Cunha L; Gonçalves AF; Oliveira C; Dinis M; Amaral R
Can J Neurol Sci; 1983 Feb; 10(1):43-6. PubMed ID: 6839227
[No Abstract] [Full Text] [Related]
14. Biogenic amine disturbances in cerebrospinal fluid in parkinsonism and unipolar depression: use of the probenecid method.
Vanderheyden JE; Noel G; Mendlewicz J
Neuropsychobiology; 1981; 7(3):137-51. PubMed ID: 6164951
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-Dopa therapy.
Korf J; van Praag HM; Schut D; Nienhuis RJ; Lakke JP
Eur Neurol; 1974; 12(5-6):340-50. PubMed ID: 4448192
[No Abstract] [Full Text] [Related]
16. Apomorphine, pimozide, L-Dopa and the probenecid test in Huntington's chorea.
Lal S; De la Vega C; Garelis E; Sourkes TL
Psychiatr Neurol Neurochir; 1973; 76(2):113-7. PubMed ID: 4267059
[No Abstract] [Full Text] [Related]
17. The probenecid test in Parkinson's disease.
Lakke JP; Korf J; Hoorntje S; Schut T; van Praag HM
Psychiatr Neurol Neurochir; 1973; 76(2):139-46. PubMed ID: 4700931
[No Abstract] [Full Text] [Related]
18. [Madopar in the treatment of paralysis agitans: II. TRH activation test, EMG examination and HVA level in cerebrospinal fluid before and after treatment].
Liu DK
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980 Apr; 13(4):223-6. PubMed ID: 6790255
[No Abstract] [Full Text] [Related]
19. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease.
Happe S; Tings T; Helmschmied K; Neubert K; Wuttke W; Paulus W; Trenkwalder C
Mov Disord; 2004 Dec; 19(12):1511-5. PubMed ID: 15390061
[TBL] [Abstract][Full Text] [Related]
20. [Cerebral metabolism of dopamine and of serotonin during Alzheimer and Pick's diseases. Dynamic study by the test using probenecid].
Guard O; Renaud B; Chazot G
Encephale; 1976; 2(4):293-303. PubMed ID: 1001240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
